Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

被引:80
|
作者
Fujisawa, Keiko [1 ]
Katakami, Naoto [1 ,2 ]
Kaneto, Hideaki [1 ]
Naka, Toyoko [1 ]
Takahara, Mitsuyoshi [1 ]
Sakamoto, Fumie [1 ]
Irie, Yoko [1 ]
Miyashita, Kazuyuki [1 ]
Kubo, Fumiyo [1 ]
Yasuda, Tetsuyuki [1 ]
Matsuoka, Taka-aki [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Suita, Osaka 5650871, Japan
关键词
sRAGE; RAGE; Cardiovascular event; Atherosclerosis; Type; 2; diabetes; GLYCATION END-PRODUCTS; CORONARY-ARTERY-DISEASE; ENDPRODUCTS RAGE; RECEPTOR; ATHEROSCLEROSIS; ASSOCIATION; SRAGE; FORM;
D O I
10.1016/j.atherosclerosis.2013.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is still controversial whether circulating soluble form of receptor for AGE (sRAGE) is associated with atherosclerosis in diabetic patients. In this study, we enrolled 276 Japanese type 2 diabetic subjects without history of cardiovascular disease (CVD), assessed their baseline clinical and biochemical data including serum sRAGE levels, and prospectively evaluated the association between these parameters and CVD events. The median follow-up period was 5.6 years and there were 25 new CVD events. The tertile analysis showed that the risk for CVD events was higher as serum sRAGE levels were increased (p for trend = 0.046). A multivariate Cox proportional hazards regression analysis revealed that serum sRAGE levels were independently associated with CVD (HR per 1SD = 1.59, 95% CI 1.04-2.45, p = 0.034), even after adjusting for conventional coronary risk factors. In summary, elevated sRAGE levels were associated with the increased risk of CVD in Japanese type 2 diabetic subjects. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [1] RENAL FUNCTION IS THE MAJOR DETERMINANT OF CIRCULATING SOLUBLE RAGE IN PATIENTS WITH TYPE 1 DIABETES
    Thomas, M. C.
    Groop, P. H.
    NEPHROLOGY, 2009, 14 : A35 - A35
  • [2] Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
    Humpert, Per M.
    Djuric, Zdenka
    Kopf, Stefan
    Rudofsky, Gottfried
    Morcos, Michael
    Nawroth, Peter P.
    Bierhaus, Angelika
    CARDIOVASCULAR DIABETOLOGY, 2007, 6 (1)
  • [3] Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
    Per M Humpert
    Zdenka Djuric
    Stefan Kopf
    Gottfried Rudofsky
    Michael Morcos
    Peter P Nawroth
    Angelika Bierhaus
    Cardiovascular Diabetology, 6
  • [4] Circulating soluble RAGE increase after a cerebrovascular event
    Menini, Teresita
    Ikeda, Hisato
    Kimura, Satoshi
    Gugliucci, Alejandro
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (01) : 109 - 116
  • [5] Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk
    Papachristou, Stella
    Popovic, Djordje S.
    Papanas, Nikolaos
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (05) : 779 - 780
  • [6] Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk
    Stella Papachristou
    Djordje S. Popovic
    Nikolaos Papanas
    International Journal of Diabetes in Developing Countries, 2023, 43 : 779 - 780
  • [7] Cardiovascular risk in patients with type 2 diabetes
    Parmar, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (09) : 1160 - 1160
  • [8] BNP Enhances Predictive Models of Cardiovascular Outcomes in Patients with Type 2 Diabetes and a Recent Coronary Event
    Wolsk, Emil
    Claggett, Brian
    Diaz, Rafael
    Dickstein, Kenneth
    Gerstein, Hertzel C.
    Kober, Lars V.
    Lawson, Francesca C.
    Lewis, Eldrin F.
    Maggioni, Aldo P.
    Mcmurray, John J. V.
    Probstfield, Jeffrey L.
    Riddle, Matthew C.
    Solomon, Scott D.
    Tardif, Jean-Claude
    Pfeffer, Marc A.
    DIABETES, 2016, 65 : A112 - A113
  • [9] Cardiovascular event costs in patients with Type 2 diabetes mellitus
    Johnston, Stephen S.
    Sheehan, John J.
    Shah, Manan
    Cappell, Katherine
    Princic, Nicole
    Smith, David
    Kalsekar, Iftekhar
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1032 - 1040
  • [10] Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
    Riquelme-Gallego, Blanca
    Garcia-Molina, Laura
    Cano-Ibanez, Naomi
    Sanchez-Delgado, Guillermo
    Andujar-Vera, Francisco
    Garcia-Fontana, Cristina
    Gonzalez-Salvatierra, Sheila
    Garcia-Recio, Enrique
    Martinez-Ruiz, Virginia
    Bueno-Cavanillas, Aurora
    Munoz-Torres, Manuel
    Garcia-Fontana, Beatriz
    SCIENTIFIC REPORTS, 2020, 10 (01)